Adaptive Phase I & II Trials

Rapid approval, flexible conduct, adaptive protocols in a MHRA accredited facility.

View service

Phase III Clinical Studies

Fast and efficient patient recruitment for Phase III clinical trials.

View service

TQT Studies

Cardiac safety assessments are built into every clinical study.

View service

Bridging Studies

Fast track your global marketing authorisations with our ethnic bridging studies.

View service

Patient Recruitment

Fast and efficient in-house team, specialising in patient recruitment.

View service

Data Management

Flexible, efficient and tailored to our clients’ needs.

View service

Latest news

Single-dose gene silencing cure for fatal heart disease comes one step closer

March 20, 2024
Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis
Read more

How Does Social Time Contribute to a Positive Workplace Culture?

March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read more

Events

ISA Symposium 2024

29-30 May 2024 
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event